Log In
BCIQ
Print this Print this
 

CA-170 (formerly AUPM-170)

  Manage Alerts
Collapse Summary General Information
Company Aurigene Discovery Technologies Ltd.
DescriptionOral small molecule antagonist of PD-L1, PD-L2 and V-region immunoglobulin-containing suppressor of T cell activation (VISTA)
Molecular Target Programmed cell death 1 ligand 1 (PD-L1) (B7-H1) (CD274) ; V-region immunoglobulin-containing suppressor of T cell activation (VISTA)
Mechanism of ActionProgrammed cell death 1 (PD-1) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/21/2015

Undisclosed

0

Undisclosed

Get a free BioCentury trial today